# Pharmacodynamics and Pharmacokinetics of 3 New Developed Coated Glucose Beads in 20 Obese Healthy Subjects

> **NCT05713773** · PHASE1 · COMPLETED · sponsor: **Aphaia Pharma US LLC** · enrollment: 20 (actual)

## Conditions studied

- Metabolic Syndrome
- Obesity

## Interventions

- **DRUG:** coated beads glucose (8 g) and caffeine anhydrous
- **DRUG:** coated beads glucose (8 g) and caffeine anhydrous
- **DRUG:** coated beads glucose (8 g) and caffeine anhydrous
- **DRUG:** coated beads glucose (8 g)
- **DRUG:** uncoated beads glucose (8 g) and caffeine anhydrous

## Key facts

- **NCT ID:** NCT05713773
- **Lead sponsor:** Aphaia Pharma US LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-25
- **Primary completion:** 2019-12-03
- **Final completion:** 2019-12-03
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2023-02-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05713773

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05713773, "Pharmacodynamics and Pharmacokinetics of 3 New Developed Coated Glucose Beads in 20 Obese Healthy Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05713773. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*